Therefore, it can be inferred that TNFAIP3 is a key effector of ZSH‐2208, which inhibits the growth of ESCC‐TRCs by indirectly reducing its expression through the inhibition of RARγ protein expression. The gene discussed is TNFAIP3; the disease is esophageal squamous cell carcinoma.